Regulatory Requirements for Stem Cell-based Therapies
This article was originally published in SRA
Executive Summary
In Part 2 of a three part series Jens Schletter, Manfred Ruediger and Sybille Esser consider regulation of stem cell-based therapies in the EU, Germany and the UK.